Medical specialists from Canada tagged as investigators in clinical trials studying Astrocytoma
Total 11 results
-
Ashley ChopekSeen in:
- Manitoba, Winnipeg, CancerCare Manitoba
Trials:- NCT04759586 (Principal Investigator)
- NCT05457556 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT03223753 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Acute Myeloid Leukemia;
- Acute Lymphoblastic Leukemia;
- Myelodysplastic Syndrome;
- Mixed Phenotype Acute Leukemia;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Malignant Glioma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- T Acute Lymphoblastic Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Juvenile Myelomonocytic Leukemia;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Hematopoietic and Lymphatic System Neoplasm
-
Bruno MichonSeen in:
- Quebec, CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL)
- Quebec, Centre Hospitalier Universitaire de Quebec
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT01790152 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Low Grade Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Osteosarcoma;
- Lymphoblastic Lymphoma;
- Recurrent Lymphoma;
- Recurrent Malignant Neoplasm;
- Hodgkin Lymphoma in Remission;
- Leukemia in Remission;
- Recurrent Leukemia;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Malignant Glioma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia
-
Craig ErkerSeen in:
- Nova Scotia, Halifax, IWK Health Centre
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT05602194 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT04089358 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Medulloblastoma;
- Neurofibromatosis Type 1;
- Low Grade Glioma;
- Visual Pathway Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Malignant Glioma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Neuroblastoma;
- Ganglioneuroblastoma;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Lymphoblastic Lymphoma;
- B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1;
- B Acute Lymphoblastic Leukemia, BCR-ABL1-Like;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Hematopoietic and Lymphoid Cell Neoplasm
-
Donna L. JohnstonSeen in:
- Ontario, Ottawa, Children's Hospital of Eastern Ontario
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT00772200 (Principal Investigator)
- NCT03223753 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Medulloblastoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Neuroblastoma;
- Ganglioneuroblastoma;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Embryonal Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Childhood Malignant Neoplasm;
- Hematopoietic and Lymphatic System Neoplasm
-
Josee BrossardSeen in:
- Quebec, Sherbrooke, Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Trials:- NCT04576117 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
Conditions:- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Neurofibromatosis Type 1;
- Low Grade Glioma;
- Visual Pathway Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Acute Myeloid Leukemia;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia
-
Lisa A. GoodyearSeen in:
- Newfoundland and Labrador, Saint John's, Janeway Child Health Centre
Trials:- NCT04759586 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT03126916 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT03223753 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Medulloblastoma;
- Low Grade Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Recurrent Neuroblastoma;
- Refractory Neuroblastoma;
- High Risk Neuroblastoma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Neuroblastoma;
- Ganglioneuroblastoma;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Mixed Phenotype Acute Leukemia;
- Hematopoietic and Lymphatic System Neoplasm
-
Monia MarzoukiSeen in:
- Quebec, Montreal, Centre Hospitalier Universitaire Sainte-Justine
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT03155620 (Principal Investigator)
- NCT02724579 (Principal Investigator)
- NCT05071209 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT05286801 (Principal Investigator)
- NCT03794349 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT05099003 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05359237 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT05828069 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Malignant Glioma;
- Rhabdoid Tumor;
- Advanced Malignant Solid Neoplasm;
- Refractory Malignant Solid Neoplasm;
- Recurrent Ependymoma;
- Recurrent Ewing Sarcoma;
- Recurrent Hepatoblastoma;
- Recurrent Langerhans Cell Histiocytosis;
- Recurrent Malignant Germ Cell Tumor;
- Recurrent Malignant Solid Neoplasm;
- Recurrent Medulloblastoma;
- Recurrent Neuroblastoma;
- Recurrent Non-Hodgkin Lymphoma;
- Recurrent Osteosarcoma;
- Recurrent Peripheral Primitive Neuroectodermal Tumor;
- Recurrent Rhabdoid Tumor;
- Recurrent Soft Tissue Sarcoma;
- Refractory Ewing Sarcoma;
- Refractory Hepatoblastoma;
- Refractory Langerhans Cell Histiocytosis;
- Refractory Malignant Germ Cell Tumor;
- Refractory Medulloblastoma;
- Refractory Neuroblastoma;
- Refractory Non-Hodgkin Lymphoma;
- Refractory Osteosarcoma;
- Refractory Peripheral Primitive Neuroectodermal Tumor;
- Refractory Rhabdoid Tumor;
- Refractory Rhabdomyosarcoma;
- Wilms Tumor;
- Langerhans Cell Histiocytosis;
- Recurrent Glioma;
- Ann Arbor Stage III Non-Hodgkin Lymphoma;
- Ann Arbor Stage IV Non-Hodgkin Lymphoma;
- Histiocytic Sarcoma;
- Juvenile Xanthogranuloma;
- Recurrent Childhood Rhabdomyosarcoma;
- Recurrent Primary Central Nervous System Neoplasm;
- Refractory Glioma;
- Refractory Primary Central Nervous System Neoplasm;
- Stage III Osteosarcoma AJCC v7;
- Stage III Soft Tissue Sarcoma AJCC v7;
- Stage IV Osteosarcoma AJCC v7;
- Stage IV Soft Tissue Sarcoma AJCC v7;
- Stage IVA Osteosarcoma AJCC v7;
- Stage IVB Osteosarcoma AJCC v7;
- Medulloblastoma;
- Refractory Lymphoma;
- Recurrent Lymphoma;
- Recurrent Alveolar Rhabdomyosarcoma;
- Refractory Alveolar Rhabdomyosarcoma;
- Neurofibromatosis Type 1;
- Low Grade Glioma;
- Visual Pathway Glioma;
- Malignant Solid Neoplasm;
- Epithelioid Sarcoma;
- Kidney Medullary Carcinoma;
- Atypical Teratoid/Rhabdoid Tumor;
- Poorly Differentiated Chordoma;
- Recurrent Atypical Teratoid/Rhabdoid Tumor;
- Recurrent Chordoma;
- Recurrent Epithelioid Sarcoma;
- Recurrent Kidney Medullary Carcinoma;
- Refractory Atypical Teratoid/Rhabdoid Tumor;
- Refractory Chordoma;
- Refractory Epithelioid Sarcoma;
- Refractory Kidney Medullary Carcinoma;
- High Risk Neuroblastoma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Glioblastoma;
- Anaplastic Astrocytoma;
- Anaplastic Astrocytoma, Not Otherwise Specified;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma, H3 K27M-Mutant;
- Glioblastoma, Not Otherwise Specified;
- Acute Lymphoblastic Leukemia;
- B Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Hematopoietic and Lymphoid Cell Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma
-
Sarah J. McKillopSeen in:
- Alberta, Edmonton, University of Alberta Hospital
Trials:- NCT04759586 (Principal Investigator)
- NCT04576117 (Principal Investigator)
- NCT03533582 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT02402244 (Principal Investigator)
- NCT05304585 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT04293562 (Principal Investigator)
- NCT00898365 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT04994132 (Principal Investigator)
- NCT03959085 (Principal Investigator)
- NCT04089358 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Recurrent WHO Grade 2 Glioma;
- Recurrent Low Grade Astrocytoma;
- Refractory Low Grade Astrocytoma;
- Refractory Low Grade Glioma;
- Refractory WHO Grade 1 Glioma;
- Hepatoblastoma;
- Fibrolamellar Carcinoma;
- Childhood Hepatocellular Carcinoma;
- Childhood Malignant Liver Neoplasm;
- Hepatocellular Malignant Neoplasm, Not Otherwise Specified;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Malignant Solid Neoplasm;
- Neuroendocrine Neoplasm;
- Myeloproliferative Neoplasm;
- Desmoid Fibromatosis;
- Lymphoproliferative Disorder;
- Carcinoma In Situ;
- Central Nervous System Neoplasm;
- Ganglioneuroma;
- Congenital Mesoblastic Nephroma;
- Childhood Immature Teratoma;
- Childhood Langerhans Cell Histiocytosis;
- Childhood Mature Teratoma;
- Stromal Neoplasm;
- Melanocytic Neoplasm;
- Embryonal Rhabdomyosarcoma;
- Fusion-Negative Alveolar Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Renal Cell Carcinoma;
- Wilms Tumor;
- Clear Cell Sarcoma of the Kidney;
- Papillary Renal Cell Carcinoma;
- Kidney Medullary Carcinoma;
- Diffuse Hyperplastic Perilobar Nephroblastomatosis;
- Rhabdoid Tumor of the Kidney;
- Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions;
- Kidney Neoplasm;
- Adult Cystic Nephroma;
- Angiolipoma;
- Cellular Congenital Mesoblastic Nephroma;
- Classic Congenital Mesoblastic Nephroma;
- Cystic Partially Differentiated Kidney Nephroblastoma;
- Extrarenal Rhabdoid Tumor;
- Kidney Oncocytoma;
- Kidney Wilms Tumor;
- Metanephric Adenofibroma;
- Metanephric Adenoma;
- Metanephric Stromal Tumor;
- Metanephric Tumor;
- Mixed Congenital Mesoblastic Nephroma;
- Ossifying Renal Tumor of Infancy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Alveolar Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma;
- Central Nervous System Leukemia;
- Testicular Leukemia;
- Hematopoietic and Lymphoid Cell Neoplasm;
- Childhood Malignant Neoplasm
-
Stephanie MouradSeen in:
- Quebec, Montreal, The Montreal Children's Hospital of the MUHC
Trials:- NCT04759586 (Principal Investigator)
- NCT03871257 (Principal Investigator)
- NCT04166409 (Principal Investigator)
- NCT03067181 (Principal Investigator)
- NCT03914625 (Principal Investigator)
- NCT03007147 (Principal Investigator)
- NCT04684368 (Principal Investigator)
- NCT05235165 (Principal Investigator)
- NCT04322318 (Principal Investigator)
- NCT03817398 (Principal Investigator)
- NCT04726241 (Principal Investigator)
- NCT05675410 (Principal Investigator)
- NCT04994132 (Principal Investigator)
Conditions:- Primary Mediastinal Large B-Cell Lymphoma;
- Neurofibromatosis Type 1;
- Low Grade Glioma;
- Visual Pathway Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Malignant Germ Cell Tumor;
- Germ Cell Tumor;
- Childhood Extracranial Germ Cell Tumor;
- Extragonadal Embryonal Carcinoma;
- Malignant Ovarian Teratoma;
- Stage I Ovarian Choriocarcinoma;
- Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage I Ovarian Teratoma AJCC v6 and v7;
- Stage I Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage I Testicular Choriocarcinoma AJCC v6 and v7;
- Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage I Testicular Seminoma AJCC v6 and v7;
- Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage II Ovarian Choriocarcinoma;
- Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage II Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage II Testicular Choriocarcinoma AJCC v6 and v7;
- Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage III Ovarian Choriocarcinoma;
- Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Stage III Testicular Choriocarcinoma AJCC v6 and v7;
- Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;
- Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;
- Stage IV Ovarian Choriocarcinoma;
- Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7;
- Stage IV Ovarian Yolk Sac Tumor AJCC v6 and v7;
- Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;
- Testicular Mixed Choriocarcinoma and Teratoma;
- Testicular Mixed Choriocarcinoma and Yolk Sac Tumor;
- Down Syndrome;
- B Acute Lymphoblastic Leukemia;
- B Lymphoblastic Lymphoma;
- Acute Lymphoblastic Leukemia;
- T Acute Lymphoblastic Leukemia;
- Mixed Phenotype Acute Leukemia;
- Choriocarcinoma;
- Embryonal Carcinoma;
- Mixed Germ Cell Tumor;
- Central Nervous System Nongerminomatous Germ Cell Tumor;
- Immature Teratoma;
- Malignant Teratoma;
- Pineal Region Germ Cell Tumor;
- Pineal Region Immature Teratoma;
- Pineal Region Yolk Sac Tumor;
- Suprasellar Germ Cell Tumor;
- Osteosarcoma;
- Metastatic Osteosarcoma;
- Metastatic Malignant Neoplasm in the Lung;
- Stage II Kidney Wilms Tumor;
- Stage III Kidney Wilms Tumor;
- Stage IV Kidney Wilms Tumor;
- Recurrent Kidney Wilms Tumor;
- Anaplastic Kidney Wilms Tumor;
- Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive;
- Acute Myeloid Leukemia;
- Juvenile Myelomonocytic Leukemia;
- Myelodysplastic Syndrome;
- Myeloid Leukemia Associated With Down Syndrome;
- Acute Myeloid Leukemia Post Cytotoxic Therapy;
- Myelodysplastic Syndrome Post Cytotoxic Therapy;
- Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8;
- Alveolar Rhabdomyosarcoma;
- Embryonal Rhabdomyosarcoma;
- Botryoid-Type Embryonal Rhabdomyosarcoma;
- Spindle Cell Rhabdomyosarcoma;
- Spindle Cell/Sclerosing Rhabdomyosarcoma;
- Metastatic Embryonal Rhabdomyosarcoma;
- Metastatic Rhabdomyosarcoma;
- Solid Alveolar Rhabdomyosarcoma
-
Uri TaboriSeen in:
- Ontario, Toronto, Hospital for Sick Children
Trials:- NCT04576117 (Principal Investigator)
- NCT03871257 (Principal Investigator)
-
Yvan SamsonSeen in:
- Quebec, Montreal, Centre Hospitalier Universitaire Sainte-Justine
Trials:- NCT04166409 (Principal Investigator)
- NCT01790152 (Principal Investigator)
- NCT02176967 (Principal Investigator)
- NCT00904241 (Principal Investigator)
- NCT00772200 (Principal Investigator)
- NCT00082745 (Principal Investigator)
Conditions:- Low Grade Glioma;
- Low Grade Astrocytoma;
- Metastatic Low Grade Astrocytoma;
- Metastatic Low Grade Glioma;
- Osteosarcoma;
- Lymphoblastic Lymphoma;
- Recurrent Lymphoma;
- Recurrent Malignant Neoplasm;
- Hodgkin Lymphoma in Remission;
- Leukemia in Remission;
- Recurrent Leukemia;
- Neuroblastoma;
- Localized Resectable Neuroblastoma;
- Localized Unresectable Neuroblastoma;
- Ganglioneuroblastoma;
- Regional Neuroblastoma;
- Stage 4S Neuroblastoma;
- Stage 4 Neuroblastoma;
- Childhood Malignant Neoplasm
Clinical Trials on Astrocytoma
-
St. Jude Children's Research HospitalRecruitingGlioma | Ganglioglioma | Pleomorphic Xanthoastrocytoma | Diffuse Astrocytoma | Pilocytic Astrocytoma | Optic Pathway Glioma | Pilomyxoid AstrocytomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Ependymoma | Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Recurrent Childhood Cerebellar Astrocytoma | Recurrent Childhood Cerebral Astrocytoma | Recurrent Childhood Subependymal Giant Cell Astrocytoma | Childhood Mixed Glioma | Childhood Oligodendroglioma and other conditionsUnited States, Canada, Australia
-
Erik MittraNational Cancer Institute (NCI)TerminatedUntreated Childhood Brain Stem Glioma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pilocytic Astrocytoma | Adult Pineal Gland Astrocytoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Pilocytic Astrocytoma | Adult Pineal Gland Astrocytoma | Recurrent Adult Brain Tumor | Adult Subependymal Giant...United States
-
National Cancer Institute (NCI)CompletedChildhood High-grade Cerebellar Astrocytoma | Childhood High-grade Cerebral Astrocytoma | Recurrent Childhood Anaplastic Astrocytoma | Recurrent Childhood Anaplastic Oligoastrocytoma | Recurrent Childhood Anaplastic Oligodendroglioma | Recurrent Childhood Cerebellar Astrocytoma | Recurrent Childhood... and other conditionsUnited States, Canada
-
National Cancer Institute (NCI)Active, not recruitingAstrocytoma, IDH-Mutant, Grade 2 | Astrocytoma, IDH-Mutant, Grade 3United States
-
Washington University School of MedicineCompletedAstrocytoma, Grade III | Astrocytoma, Grade IV | Grade IV Astrocytoma | Grade III AstrocytomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Ependymoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Myxopapillary Ependymoma | Adult Oligodendroglioma | Adult Pilocytic... and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Millennium Pharmaceuticals, Inc.CompletedAdult Anaplastic Astrocytoma | Adult Anaplastic Ependymoma | Adult Anaplastic Oligodendroglioma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pilocytic Astrocytoma | Adult Pineal Gland Astrocytoma | Recurrent... and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedAdult Anaplastic Astrocytoma | Adult Diffuse Astrocytoma | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | Adult Mixed Glioma | Adult Oligodendroglioma | Adult Pineal Gland AstrocytomaUnited States